baber/WOPTO huggingface dataset:
Patent NZ-201392-A (NZ)
Title: Tamperproof document:information carrier bonded to transparent foil by means of poly-1,2-alkyleneimine-containing layer
Inventor: BOCHOW R
IPC: G03C1/76
Filed: 1982-07-27
Abstract: The tamper-proof document consists of a photographic material as information carrier comprising front- and back gelatine layers, the outer of the gelatine layers of which contain particles of a homo- or copolymer of an acrylic and/or methacrylic acid ester. The information carrier is laminated on one or both sides to a transparent foil by means of a hardenable adhesive. The document is remarkably safe against falsification.
Patent NZ-206748-A (NZ)
Title: Thermal camouflage laminated material includes cracked metallic layer
Inventor: KARLSSON L
IPC: F41H3/02
Filed: 1984-01-05
Abstract: The invention relates to a thermal camouflage comprising a strengthening layer (4), e.g. a woven material, on which a polyethylene film layer (1), metallized on one side, has been laminated with the aid of fusion adhesive (3). On lamination the surface is embossed such as to make it mat. Since the polyethylene is transparent for infrared, it has low self-radiation. By means of the metal layer (2) there is obtained radiation insulation so that the outer layer (1) is in a thermal equilibrium which is hardly affected, e.g. by a warm object which is covered with the material, and the outer layer has a low emission ability of about 0.6-0.8, depending on thickness and pigmentation. By applying further layers (5), patchy images may be obtained with infrared reproduction in the wavelength ranges of 3-5  mu m and 8-14  mu m.
Patent NZ-223637-A (NZ)
Title: Self-contained immunoassay element
Inventor: GRENNER GERD
IPC: B01L3/00
Filed: 1988-02-25
Abstract: An element for analysis of a liquid sample including a capillary containing a fixed reagent in fluid communication with reagent reservoirs and a waste liquid reservoir. A sample introducing means is provided which permits analyte in a sample to interact with the fixed reagent. A labelled reagent is provided which interacts with either the fixed reagent or the analyte in a manner which permits detection of the concentration of analyte in the sample. The capillary, reagent reservoirs, waste liquid reservoir and the sample introducing means are arranged within a common housing so that reagent waste liquid need not be removed from the element.
Patent NZ-239591-A (NZ)
Title: Tryptophan derivatives and pharmaceutical compositions
Inventor: HORWELL DAVID CHRISTOPHER
IPC: A61K31/404
Filed: 1991-08-29
Abstract: Novel pro-drugs to new and unnatural depeptoids of  alpha -substituted Trp-Phe derivatives useful as agents in the treatment of obesity, hypersecretion of gastric acid in the gut, gastrin-dependent tumors, or as antipsychotics are disclosed. Further, the dipeptoids are antianxiety agents and antiulcer agents. They are agents useful for preventing the response to the withdrawal from chronic treatment or with use of nicotine, diazepam, alcohol, cocaine, caffeine, or opioids. The pro-drugs are also useful in treating and/or preventing panic attacks. Also disclosed are pharmaceutical compositions and methods of treatment using the pro-drugs as well as processes for preparing them and novel intermediates useful in their preparation. An additional feature of the invention is the use of the subject pro-drug compounds in diagnostic compositions.
Patent NZ-245240-A (NZ)
Title: Coating metal with a powder-coating containing epoxy resin and uv light absorber or hindered amine light stabilizer
Inventor: SAMMEL RICHARD K
IPC: C09D5/03
Filed: 1992-11-24
Abstract: Bright, non-anodized aluminum wheel covers and other like trim on automobiles subject to the disfiguring effects of filiform corrosion are given prolonged life by the protection of a powder coating containing a UV absorber, a light stabilizer or mixture thereof, and a small amount of an epoxy resin which does not lessen the weatherability of the coating. The powder composition is baked on to give a clear coating.
Patent NZ-246571-A (NZ)
Title: Human kunitz-type protease inhibitor, variants and compositions
Inventor: NORRIS FANNY
IPC: C07K14/81
Filed: 1993-01-07
Abstract: The present invention relates to a human Kunitz-type protease inhibitor comprising the following amino acid sequenceAsp Leu Leu Pro Asn Val Cys Ala Phe Pro Met Glu Lys Gly Pro Cys Gln Thr Tyr Met Thr Arg Trp Phe Phe Asn Phe Glu Thr Gly Glu Cys Glu Leu Phe Ala Tyr Gly Gly Cys Gly Gly Asn Ser Asn Asn Phe Leu Arg Lys Glu Lys Cys Glu Lys Phe Cys Lys Phe Thr(SEQ ID NO:1)or a variant thereof with protease inhibitor properties.
Patent NZ-274807-A (NZ)
Title: Automated liquid dispenser actuated by selected keys on dispenser support for respective different liquids being actuated by mounting suitably profiled container
Inventor: CROSSDALE GARRY WILLIAM
IPC: B67C3/28
Filed: 1994-10-31
Abstract: PCT No. PCT/CA94/00600 Sec. 371 Date Jun. 26, 1996 Sec. 102(e) Date Jun. 26, 1996 PCT Filed Oct. 31, 1994 PCT Pub. No. WO95/12544 PCT Pub. Date May 11, 1995A dispenser for filling with liquid a container of a predetermined profile comprising a support for the container to be filled, a plurality of sources of different liquids, valves for regulating the flow of liquid from the sources into the container, a series of keys on the support, each key being movable between at least two positions, switches actuated by the respective keys, and a control connected between the switches and the valves. On mounting of a particular container on the support, the keys are moved a predetermined way by the container's predetermined profile and the control in response to the keys being moved fills the correct liquid into the container.
Patent NZ-287497-A (NZ)
Title: Paper manufacture by flocculating a thick stock cellulose suspension by adding a cationic charge density polymer, diluting and coagulating the stock, adding an anionic colloidal material and draining the stock to form a sheet
Inventor: CUTTS PAUL KENNETH
IPC: D21H17/45
Filed: 1995-06-01
Abstract: Paper is made by forming a thick stock cellulosic suspension, flocculating the thick stock by adding a relatively high molecular weight and relatively low cationic charge density polymer, diluting the flocculated thick stock to form a thin stock and then draining the thin stock to form a sheet. Usually coagulant is added to the thin stock before drainage and best results are achieved by adding coagulant followed by anionic colloidal material such as bentonite. The process can be operated to give good retention and good formation and, if the thick stock is dirty, to minimise pitch problems.
Patent NZ-307021-A (NZ)
Title: Pyrido[2,3-d]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
Inventor: BLANKLEY CLIFTON JOHN
IPC: A61P43/00
Filed: 1996-04-26
Abstract: A compound of the formula wherein:  X is NH, N-Acyl, O, or S; R1 is SOR3 or SO2 R3; R2, R3, and R4 independently are hydrogen, (CH2)nPh (wherein Ph is phenyl or substituted phenyl and n is 0, 1, 2, or 3), heteroaromatic, cycloalkyl, alkanoyl, alkyl, alkenyl, or alkynyl; wherein the alkyl, alkenyl, and alkynyl groups may be substituted by NR5R6, phenyl, substituted phenyl, thioalkyl, alkyloxy, hydroxy, carboxy, halogen, or cycloalkyl, and wherein R5 and R6 are independently hydrogen, alkyl, alkenyl, alkynyl, (CH2)nPh, cycloalkyl, or heteroaromatic, and R5 and R6 taken together with the nitrogen to which they are attached can complete a ring having 3 to 7 carbon atoms and optionally containing 1, 2, or 3 heteroatoms selected from nitrogen, oxygen, and sulfur; R4 can additionally be -C(O)R3, --C(O)OR3, --SO2R3, --SO2NR5R6, -C(O)NR5R6, -C(S)NR5R6, -C(NH)R3, -C(NH)NR5R6, and R3 and R4 can be taken together with the nitrogen to which they are attached to complete a ring having 3 to 7 carbon atoms and optionally containing 1, 2, or 3 heteroatoms selected from nitrogen, oxygen, and sulfur; Ar is phenyl, substituted phenyl, or heteroaromatic; and the pharmaceutically acceptable salts thereof. These compounds are useful for treating diseases mediated by cellular proliferation.
Patent NZ-316787-A (NZ)
Title: Methods and compositions for the selective modification of nucleic acids
Inventor: ACKERMAN SAMUEL K
IPC: A61K39/235
Filed: 1996-08-29
Abstract: This application provides means and methods of inactivating viruses and other organisms in cell-containing or biopolymer-containing compositions without significant alteration of proteins or other biopolymers by contacting such compositions with selective ethyleneimine oligomer inactivating agents, such as the trimer or tetramer.
Patent NZ-333950-A (NZ)
Title: Selective preparation process of acetic acid from a feed gas such as ethane and catalysts containing Mo Pd X and Y therefor
Inventor: BORCHERT HOLGER
IPC: B01J23/652
Filed: 1997-07-16
Abstract: A process for the selective preparation of acetic acid from a gaseous feed comprising ethane, ethylene or mixtures thereof plus oxygen at elevated temperature by bringing the gaseous feed into contact with a Mo, Pd, X and Y catalyst in gram ratios a:b:c:d in combination with oxygen MoaPdbXcYd Where X is one or more elements selected from  Cr, Mn Nb, Ta, Ti, V, Te and W Y is B, Al, Ga, In, Pt, Zn, Cd, Bi, Ce, Co, Rh, Ir, Cu, Ag, Au, Fe, Ru, Os, K, Rb, Cs, Mg, Ca, Sr, Ba, Zr, Hf, Ni, P, Pb, Sb, So, Sn, Tl and U; a=1 b>0 c>0 d=0-2 with the proviso that the catalyst contains at least Nb and V and that Mo and X are no members selected from the group consisting of heteropoly-oxides and their salts.
Patent NZ-334634-A (NZ)
Title: Use of a protein extracted from mammalian liver for treating HIV
Inventor: BARTORELLI ALBERTO
IPC: A61K38/00
Filed: 1997-09-11
Abstract: The use in the preparation of medicaments to treat infections caused by HIV of a protein extractable from mammalian liver with perchloric acid where the protein has at least 80% homology with the sequence 1.
Patent NZ-500620-A (NZ)
Title: Synthetic peptides which inhibit serine proteases, specifically thrombin, factor VIIa tissue factor and factor Xa
Inventor: ADANG ANTON EGBERT PETER
IPC: C07K5/00
Filed: 1998-04-28
Abstract: The specification describes a compound having the formula (I):  R1SO2-B-X-Z-C(O)-Y, wherein B is a bond, an amino acid of the formula -NH-CH[(CH2)pC(O)OH]-C(O)- or an ester derivative thereof wherein p is 1, 2, or 3, Gly, D-1-Piq, D-3-Piq, D-1-Tiq, D-3-Tiq, D-Atc, Aic, or a L- or D-amino acid having a hydrophobic, basic or neutral side chain; X is an amino acid with a hydrophobic side chain, glutamine, serine, threonine, a cyclic amino acid optionally containing an additional heteroatom selected from N, O or S, and optionally substituted with (1-6C)alkyl, (1-6C)alkoxy, benzyloxy or oxo, or X is 2-amino-isobutyric acid, -NR2-CH2-C(O)- or the fragment (I) or (II) as depicted above, wherein n is 2, 3, or 4, W is CH or N and R3 is H, (1-6C)alkyl or phenyl which groups may optionally be substituted with hydroxy, (1-6C)alkoxy, COOH, COO(1-6C)alkyl, CONH2, or halogen; Z is lysine or 4-aminocyclohexylglycine. The compounds of the invention have anticoagulant activity and can be used in treating or preventing thrombin-related diseases. The variable R1 and Y are defined in the body.
Patent NZ-504951-A (NZ)
Title: Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
Inventor: ANDERSEN PETER
IPC: G01N33/569
Filed: 1998-10-08
Abstract: A substantially pure Mycobacterium tuberculosis derived polypeptide fragment having the amino acid sequence as shown in SEQ ID NO: 175, 177, 179, 181, 183 or 185 is disclosed with SEQ ID No 175 and 177 being preferred. Also disclosed is a fusion polypeptide containing at least one of the polypeptide fragments defined above and fusion partner. An isolated nucleic acid fragment encoding a polypeptide fragment as defined above and a vector comprises the nucleic acid fragment is disclosed. A vaccine composition or an immunologic composition containing the above defined polypeptide fragment is useful for immunizing an animal against tuberculosis caused by mycobacteria belonging to the tuberculosis complex.
Patent NZ-506806-A (NZ)
Title: (4-Arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides, pharmaceuticals thereof and their use as inhibitors of mammalian reprolysin or matrix metalloproteinase
Inventor: REITER LAWRENCE ALAN
IPC: C07D309/14
Filed: 1999-03-24
Abstract: A compound of formula I; where: Q is alkyl, aryl, heteroaryl, aryloxyalkyl, aryloxyaryl, aryloxyheteroaryl, arylalkyl, arylaryl, arylheteroaryl, arylarylalkyl, arylarylaryl, arylarylheteroaryl, heteroarylalkyl, heteroarylaryl, heteroarylheteroaryl, arylalkoxyalkyl, arylalkoxyaryl, arylalkoxyheteroaryl, heteroaryloxyalkyl, heteroaryloxyaryl, heteroaryloxyheteroaryl, heteroarylalkoxyalkyl, heteroarylalkoxyaryl or heteroarylalkoxyheteroaryl. Each aryl and heteroaryl group is optionally substituted. With the proviso that the compound of formula I is not 4-[4(4-fluorophenoxy)-benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxamide. Also described is a pharmaceutical composition comprising the compound of formula I and a pharmaceutically acceptable carrier. The compounds of formula I are useful for the inhibition of matrix metalloproteinases or for the inhibition of mammalian reprolysin. The compounds of formula I are particularly useful for the treatment of arthritis, inflammatory bowel disease, Crohn's disease, emphysema, chronic obstructive pulmonary disease, Alzheimer's disease, organ transplant toxicity, cachexia, allergic reactions, allergic contact hypersensitivity, cancer, tissue ulceration, restenosis, periodontal disease, epidemolysis bullosa, osteoporosis, loosening of artificial joint implants, atherosclerosis, aortic aneurysm, congestive heart failure, myocardial infarction, stroke, cerebral ischemia, head trauma, spinal cord injury, neuro-degenerative disorders, autoimmune disorders, Huntington's disease, Parkinson's disease, migraine, depression, peripheral neuropathy, pain. cerebral amyloid angiopathy, nootropic or cognition enhancement, amyotrophic lateral sclerosis, multiple sclerosis, comeal injury, macular degeneration, abnormal wound healing, bums, diabetes, tumour invasion, tumour growth, tumour metastasis, comeal scarring, scleritis, AIDS, sepsis and septic shock.
Patent NZ-508291-A (NZ)
Title: Use of acetaminophen in a medicament for treating migraine symptoms
Inventor: CODISPOTI JOSEPH R
IPC: A61K31/167
Filed: 2000-11-20
Abstract: Acetaminophen, a pharmaceutically acceptable salt,  or mixture thereof is used as the sole pharmaceutically effective ingredient in the manufacture of a medicament suitable for migrating or treating photophobia of phonophobia associated with a migraine. The pharmaceutically acceptable salt of acetaminophen is selected from: Inorganic salts of acetaminophen with sodium, calcium, lithium, potassium, cesium, ammonia, ferrous, zinc, manganous, aluminum, ferric and manganic, organic salts of acetaminophen with primary, secondary, tertiary and quaternary amines, substituted amines and basic ion exchange resins and mixtures thereof.
Patent NZ-511632-A (NZ)
Title: Magnetic tape on carriageway vehicle guidance system with differential sensor
Inventor: SEIFERLING JAMES EDWARD
IPC: B62D1/28
Filed: 2001-05-10
Abstract: To guide a vehicle along a roadway provided with an elongate magnetic field emitting guide member, upper and lower sensors are connected to the vehicle.  The lower sensor detects a magnetic field emitted by the elongate guide member and an ambient magnetic field.  The upper sensor detects only the ambient magnetic field.  The signals produced by the sensors are processed to subtract the signal from the upper sensor from the signal produced from the lower sensor to produce a steering signal for transmission to an automatic steering system on the vehicle.
Patent NZ-511709-A (NZ)
Title: Implant for implantation in humans or animals comprising flexible, thread-shaped elements
Inventor: EDBERG BENGT
IPC: A61L27/00
Filed: 1999-11-25
Abstract: A porous, in humans or animals biodegradable, biocompatible implant for implantation in humans or animals, the implant comprising flexible, thread-shaped elements. The thread-shaped elements consist of a number of thread bundles (1) containing up to several thousand threads (2) which in turn contain 50 to 500 filaments with a combined density of 5 to 120 tex. The thread bundles (1) have a twist of 0 to 150 revolutions per metre and are held together by weft threads (3) with a distribution density of a few threads per cm up to roughly 100 threads per cm calculated in the longitudinal direction of the thread-shaped element.
Patent NZ-515301-A (NZ)
Title: Pharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction
Inventor: MATUSCH RUDOLF
IPC: A61P25/04
Filed: 2000-05-17
Abstract: The invention relates to pharmaceutical preparations that are used in a method for treating opiate addiction or opiate dependence, especially heroin dependence. The active substance used is preferably diamorphine and/or one of the pharmaceutically acceptable acid addition salts thereof. The invention also relates to the treatment of opiate dependence.
Patent NZ-515723-A (NZ)
Title: Rope hitch where the rope is secured in passages between adjacent edges of a wedge and cam plates
Inventor: RADFORD WAYNE MICHAEL
IPC: B60P7/08
Filed: 2000-05-25
Abstract: A rope hitch (1) to facilitate the tie down and/or tensioning of ropes (11) in various situations is provided with a cam locking system and a rope block (6).   A rope hitch (1) has a mounting plate (2), opposed cam plates (3) mounted on a major surface of the mounting plate, a wedge (5) fixed between the cam plates, and a rope block (6) mounted on the major surface of the mounting plate in a position adjacent to the cam plates and the wedge.  The arrangement being such that a rope can be secured in a passages created between adjacent edges of the wedge and the cam plates and passed over the block to tension and lock same with respect to remote tie-down or fixture points. Ropes attached to the hitch can be tensioned and shortened with minimal effort.
Patent NZ-516339-A (NZ)
Title: Vitamin D3 (cholcalciferol) derivatives
Inventor: BATCHO ANDREW DAVID
IPC: C07C401/00
Filed: 2000-07-06
Abstract: Compounds of formula (I) wherein: R1 and R2 are hydrogen or alkyl group, or R1, R2, and C20 together are cyclopropyl, A is (II), (III), (IV), (V), R3 and R4 are alkyl, hydroxyalkyl or fluoroalkyl. Uses of these compounds are covered, including: treatment of osteoporosis, baldness, sebaceous gland diseases, cancers, and benign prostate growth.
Patent NZ-516366-A (NZ)
Title: Increased lifespan formulation using pine bark flavonoid extract
Inventor: DUNCAN KELVIN WINSTON
IPC: A61K31/7048
Filed: 2001-12-24
Abstract: Disclosed is the use of flavonoids extracted from pine bark in the manufacture of a composition for the treatment of decreasing the rate of senescence of a mammal's whole body after onset of senescence; wherein senescence is defined as the deterioration of bodily functions that accompanies aging in a living mammal.
Patent NZ-517119-A (NZ)
Title: Use of low-molecular-weight heparins for preventing and treating central nervous system (CNS) trauma
Inventor: STUTZMANN JEAN-MARIE
IPC: A61K31/715
Filed: 1998-05-25
Abstract: Use of a low molecular weight heparin for the treatment and or prevention of trauma of the central nervous system, excluding craniospinal trauma. The low molecular weight heparin may consist of: - oligosaccharides having a 2-0-sulpho-4-enopyranosuronic acid at one of their ends, - a low molecular weight heparin obtained by depolymerisation of a heparin ester by means of a base, or - a low molecular weight heparin selected from enoxaparin, nadroparin, parnaparin, reviparin, dalteparin, tinzaparin, danaparin, ardepari n, certoparin, CY222 and SR90107/ORG31540.
Patent NZ-517332-A (NZ)
Title: Pet food package
Inventor: FIALA RALF
IPC: B65D71/00
Filed: 2000-08-22
Abstract: A  pet food package for canned pet foods.  The package contains  one  or more cans (50) and a carrier  (40).   Each can  has a flexible, peelable lid which is heat sealed  onto the  can.   The  lid  is  relatively easy  to  remove.   The carrier  is  a fibre-based board which is folded around  the cans.   The  board  has slots cut into it which  receive  an upper  seam (58) of the cans to hold the cans.  The  carrier protects  the lid of the cans and releasably holds the  cans in  place.  The  cans may be sized for single  servings  and hold  food of different flavours, so as to help avoid  taste fatigue.
Patent NZ-520070-A (NZ)
Title: Improved method of analysis
Inventor: WILSON PAUL FRANCIS
IPC: H01J49/04
Filed: 2002-07-09
Abstract: Disclosed is a method of detecting and quantifying trace levels of molecules containing one or more of a range of reactive species, in gases or gas mixtures consisting of alkanes, ethene, or ethyne, the method including using an alkoxyalkyl cation as the chemical ionisation precursor in a selected ion flow tube mass spectrometer. Also disclosed is a method of detecting and quantifying a gas sample containing trace levels of molecules containing one or more of a range of reactive species, in gases or gas mixtures consisting of alkanes, ethene, or ethyne in a selected ion flow tube mass spectrometer comprising the steps of: (a) producing a supply of alkyoxymethyl cations, (b) mass electing the alkyoxymethyl cations, (c) inducing a flow of the alkyoxymethyl cations into the inlet of a flow tube of the spectrometer in a carrier flow of helium, (d) reacting the gas sample with the alkyoxymethyl cations, (e) analysing the reacted gas sample in the mass spectrometer, and (f) calculating the concentration of the trace levels of molecules containing heteroatoms present in the reacted gas sample.
Patent NZ-521944-A (NZ)
Title: Candle product decorated with heat-shrinkable film and related method
Inventor: KOTARY KARA L
IPC: B44C1/10
Filed: 2001-03-30
Abstract: A method of decorating a candle product, comprising the steps of: providing a web of a heat-shrinkable polymer having a decorative feature; encasing with the web one of a candle and a candle holder; after the encasing step, heating the web to shrink the web to conform to a shape of the one of the candle and the candle holder; and in a case in which the one of the candle and the candle holder is the candle holder, positioning the candle in the candle holder.
Patent NZ-523763-A (NZ)
Title: Compostion and method for the repair and regeneration of cartilage and other tissues
Inventor: HOEMANN CAROLINE D
IPC: A61L27/50
Filed: 2001-06-29
Abstract: A method for repairing a tissue of a non-human patient, said method comprising the step of introducing a polymer composition in said tissue, said polymer composition comprising a modified or natural polysaccharide polymer, a polyol phosphate diabasic salt or a glucosamine, and being mixed with at least one blood component selected from the group consisting of whole blood, processed blood, venous blood, arterial blood, blood from bone, blood from bone-marrow, bone marrow, umbilical cord blood, placenta blood, erythrocytes, leukocytes, monocytes, platelets, fibrinogen, thrombin, platelet rich plasma free of erythrocytes, tissue factor, a phospholipid, and a coagulation factor, said polymer composition when mixed with said blood component results in a mixture, said mixture turning into a non-liquid state in time or upon heating, said mixture being retained at the site of introduction and adhering thereto for repairing the tissue.